Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2026 15:15 ET | Source: Tevogen Bio Inc

Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform

Tevogen advances TVGN 489 for Long COVID, expanding HLA coverage to 65% of U.S. population and integrating digital monitoring capabilities.
March 10, 2026 10:00 ET | Source: Medidata Solutions, Inc.

AI Takes Center Stage at NEXT New York: Medidata Showcases AI Companions and Orchestrated Intelligence Transforming Life Sciences

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and global leader in clinical trial solutions, today unveiled a transformative vision for the life sciences industry at...
March 09, 2026 09:00 ET | Source: Medidata Solutions, Inc.

Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a strategic...
March 04, 2026 08:00 ET | Source: Medidata Solutions, Inc.

Medidata and CRIO Empower Over 2,500 Global Research Sites with Seamless Integration to Accelerate Clinical Trials

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has announced a partnership with...
March 03, 2026 08:00 ET | Source: Medidata Solutions, Inc.

Medidata’s Experience-based AI Earns Top Luminary Rating in Everest Group 2026 Review

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has secured the highest “Luminary”...
February 12, 2026 11:07 ET | Source: Research and Markets

Global Pharmaceutical R&D Directory 2026: Licensing Trends, Biotechnology Advancements, Preclinical and Clinical Development, Avenues for Growth and Innovation

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "The Global Pharmaceutical R&D Directory" directory has been added to ResearchAndMarkets.com's offering. The Global Pharmaceutical R&D...
February 05, 2026 07:18 ET | Source: Research and Markets

Crohn's Disease (Regional Enteritis) Global Clinical Trials Market Review 2025: G7 and E7 Activities, Trial Status, Sponsor Insights, Enrollment Trends, Company Listings, Unaccomplished Trials

Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
January 23, 2026 09:58 ET | Source: Research and Markets

MYC Targeting Therapies Market Research Report 2026-2030: 10 Therapies in Clinical Trials, 5 Targeting Platforms, Clinical Studies Start & Expected Completion Timeline by Indication

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "MYC Targeting Therapies Market Opportunity, Targeting Approaches, Technology Development Platforms & Clinical Trials Insight 2026" report has been...
January 14, 2026 19:00 ET | Source: Psyence Biomedical Ltd.

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation...
January 07, 2026 09:00 ET | Source: Genmab A/S

Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence

Media ReleaseCOPENHAGEN, Denmark; January 07, 2026 Supports Genmab’s ambition to build an AI-enabled innovation model that advances the company’s vision of bringing transformative antibody...